MEDirect Latino Inc. Launches National Media Campaign September 20 on Telemundo Network

Media Campaign Targets 4.1 Million Hispanic Medicare Eligible Customers


PLANTATION, Fla., Sept. 14, 2005 (PRIMEZONE) -- MEDirect Latino Inc. (Pink Sheets:MLTO) (http://www.medirectlatino.org), the leading provider of direct-to-consumer Medicare reimbursed healthcare products to the Hispanic community, today announced the launch of the Company's national media campaign on Telemundo Television Network to begin the week of September 19, 2005.

Mr. Charles W. Hansen III, COO of MEDirect Latino, and director of the Company's media program stated, "The launch of our national media campaign has been carefully researched and targeted to substantially increase our customer base and maximize revenue projections. The Company's psychographic, demographic, lifestyle data and proprietary algorithms, supported by our ongoing customer feedback, are factors in determining media type, day part and cost per thousands (cpms) of our marketing campaigns. We chose Telemundo to launch our national campaign over other broadcast providers as our proprietary research demonstrated that a large concentration of our customers were loyal Telemundo viewers. We will continue to develop the MEDirect Latino brand and customer base through strategic selection of additional Anglo and Hispanic media as appropriate," stated Hansen. "The comprehensive media campaign for the remainder of this year, and the amount we have budgeted for 2006, will garner a substantial share of market and it will certainly raise a few eyebrows among media reps. In the end the campaign will translate to cost effective media placement as we continue to build our proprietary Hispanic healthcare database and service our customers."

Mr. Raymond Talarico, Co-Chairman and CEO of MEDirect Latino noted, "We have spent a considerable amount of time and capital in building a completely bilingual infrastructure which services the Hispanic Medicare patient. The success of our model is evident from the August operating results that were announced this past Monday. We have significantly increased the number of bilingual personnel across the board -- customer service representatives, billing specialists and compliance personnel in order to handle the considerable increase in our customer intake volume. Based upon the success that we have achieved in Puerto Rico, we expect the national campaign, coupled with our continuing program in Puerto Rico to result in 3,000 - 4,000 new customers monthly and steadily increase as the campaign builds traction."

Additional Company information may be obtained by reviewing a detailed analytical profile generated by small cap analyst, Mr. Gerald Kieft, President, Wall Street Resources. The detailed report includes information on the Company's business model, products, industry, valuation, management, and risk.

Available: http://www.wallstreetresources.net/pdf/fc/MLTO.pdf

ABOUT MEDIRECT LATINO:

MEDirect Latino (Pink Sheets:MLTO) (www.medirectlatino.org) is a rapidly growing, uniquely positioned provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community in the United States and Puerto Rico. MEDirect is the only company positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. The Company's current focus is the distribution of products for the treatment of Type II diabetes specifically because of its disproportionate impact and increasing diagnosis rate within the U.S. Hispanic population, noting an incidence of 120% higher than among non-Hispanic whites.

The current Hispanic market for MEDirect's products is conservatively estimated at approximately $650MM in the continental United States. The size of the opportunity is understated by such figures as an estimated 925,000 of the over 3.1 million Hispanics in the United States over 65 eligible to receive Medicare benefits are currently collecting these benefits with an estimate that over 1.4 million of those Medicare-eligible Hispanics have diabetes (implying a potential continental U.S. market for MEDirect products of approximately $1 billion).

FORWARD LOOKING STATEMENTS:

Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. The Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this press release, the Company will appropriately inform the public.

The MEDirect Latino Inc. company logo can be found at: http://www.primezone.com/newsroom/prs/?pkgid=1873



            

Kontaktdaten